Evidence map›Paper›PMID 33506025›Full record

ArticleBioMed research international2021

Donor Preconditioning with Inhaled Sevoflurane Mitigates the Effects of Ischemia-Reperfusion Injury in a Swine Model of Lung Transplantation.

Alessandro Bertani, Vitale Miceli, Lavinia De Monte, Giovanna Occhipinti, Valeria Pagano, Rosa Liotta, Ester Badami, Fabio Tuzzolino, Antonio Arcadipane

Open access · hybridAbstract read
In one paragraph

Article in BioMed research international, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.7field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 10 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Alessandro BertaniDivision of Thoracic Surgery and Lung Transplantation, Department for the Treatment and Study of Cardiothoracic Diseases and Cardiothoracic Transplantation, IRCCS-ISMETT, Palermo, Italy.ORCID https://orcid.org/0000-0003-1684-3259
Vitale MiceliResearch Department, IRCCS-ISMETT, Palermo, Italy.
Lavinia De MonteDivision of Thoracic Surgery and Lung Transplantation, Department for the Treatment and Study of Cardiothoracic Diseases and Cardiothoracic Transplantation, IRCCS-ISMETT, Palermo, Italy.
Giovanna OcchipintiDepartment of Anesthesiology and Critical Care, IRCCS-ISMETT, Palermo, Italy.
Valeria PaganoFondazione Ri.MED, Palermo, Italy.
Rosa LiottaDepartment of Pathology, IRCCS-ISMETT, Palermo, Italy.
Ester BadamiFondazione Ri.MED, Palermo, Italy.
Fabio TuzzolinoResearch Department, IRCCS-ISMETT, Palermo, Italy.
Antonio ArcadipaneDepartment of Anesthesiology and Critical Care, IRCCS-ISMETT, Palermo, Italy.
Istituti di Ricovero e Cura a Carattere Scientifico · ITIstituto Mediterraneo per i Trapianti e Terapie ad Alta Specializzazione · ITRi.MED · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Primary graft dysfunction (PGD) and ischemia-reperfusion injury (IRI) occur in up to 30% of patients undergoing lung transplantation and may impact on the clinical outcome. Several strategies for the prevention and treatment of PGD have been proposed, but with limited use in clinical practice. In this study, we investigate the potential application of sevoflurane (SEV) preconditioning to mitigate IRI after lung transplantation. The study included two groups of swines (preconditioned and not preconditioned with SEV) undergoing left lung transplantation after 24-hour of cold ischemia. Recipients' data was collected for 6 hours after reperfusion. Outcome analysis included assessment of ventilatory, hemodynamic, and hemogasanalytic parameters, evaluation of cellularity and cytokines in BAL samples, and histological analysis of tissue samples. Hemogasanalytic, hemodynamic, and respiratory parameters were significantly favorable, and the histological score showed less inflammatory and fibrotic injury in animals receiving SEV treatment. BAL cellular and cytokine profiling showed an anti-inflammatory pattern in animals receiving SEV compared to controls. In a swine model of lung transplantation after prolonged cold ischemia, SEV showed to mitigate the adverse effects of ischemia/reperfusion and to improve animal survival. Given the low cost and easy applicability, the administration of SEV in lung donors may be more extensively explored in clinical practice.

Indexed as

Reperfusion InjurySevofluraneTransplantsAdministration, InhalationAnesthetics, InhalationAnimalsDisease Models, AnimalIschemic PreconditioningLungLung TransplantationSus scrofaSwineAnesthetics, InhalationSevoflurane

Identifiers

PMID33506025
PMCPMC7815409
OpenAlexW3118461584

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.